MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,356,141 | +91.9% | 106,207 | +57.1% | 0.00% | +200.0% |
| Q2 2023 | $1,748,502 | +154.6% | 67,588 | +136.4% | 0.00% | 0.0% |
| Q1 2023 | $686,660 | +78.3% | 28,587 | +44.7% | 0.00% | – |
| Q4 2022 | $385,184 | -74.2% | 19,753 | -72.2% | 0.00% | -100.0% |
| Q3 2022 | $1,492,000 | +68.2% | 71,009 | +55.8% | 0.00% | +100.0% |
| Q2 2022 | $887,000 | +233.5% | 45,570 | +276.7% | 0.00% | – |
| Q1 2022 | $266,000 | -10.7% | 12,098 | -35.1% | 0.00% | – |
| Q4 2021 | $298,000 | -24.7% | 18,653 | -6.1% | 0.00% | – |
| Q3 2021 | $396,000 | +65.0% | 19,865 | +43.2% | 0.00% | – |
| Q2 2021 | $240,000 | -64.2% | 13,874 | -59.0% | 0.00% | -100.0% |
| Q1 2021 | $671,000 | +15.3% | 33,874 | +1.6% | 0.00% | 0.0% |
| Q4 2020 | $582,000 | +168.2% | 33,333 | +276.9% | 0.00% | – |
| Q4 2019 | $217,000 | – | 8,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 1,921,118 | $38,077,000 | 5.86% |
| FRAZIER MANAGEMENT LLC | 3,566,912 | $70,696,000 | 5.67% |
| Burrage Capital Management LLC | 205,866 | $4,080,000 | 3.31% |
| Novo Holdings A/S | 2,445,147 | $48,463,000 | 2.00% |
| NEA Management Company, LLC | 4,187,801 | $83,002,000 | 1.86% |
| Sio Capital Management, LLC | 437,138 | $8,664,000 | 1.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $68,357,000 | 1.44% |
| Rock Springs Capital Management LP | 1,502,800 | $29,785,000 | 0.65% |
| Sofinnova Investments, Inc. | 476,401 | $9,442,000 | 0.57% |
| Boxer Capital, LLC | 317,000 | $6,283,000 | 0.21% |